Devika Das, Associate Director Clinical Affairs at the University of Mississippi Medical Center, shared a post on LinkedIn:
“If cost and access (hopefully) is not a barrier or prohibitive, this is going to be a phenomenal addition to our options for cancer treatment.
Subcut formulations mean shorter chair time for patients and if done correctly, we could provide more treatments per day- specially in under resourced settings.
Grateful for this approval!”
More posts featuring Cancer Treatment.